Richard G. Ghalie - 05 Jul 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Chief Medical Officer
Signature
/s/ Brian G. Drazba, as attorney in fact
Issuer symbol
MEIP
Transactions as of
05 Jul 2022
Net transactions value
-$4,426
Form type
4
Filing time
07 Jul 2022, 16:17:16 UTC
Previous filing
06 Jul 2021
Next filing
12 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEIP Common Stock Tax liability $4,426 -8,196 -22% $0.5400* 28,927 05 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +560,000 $0.000000 560,000 05 Jul 2022 Common Stock 560,000 $0.5400 Direct F2
holding MEIP Stock Option (Right to Buy) 320,000 05 Jul 2022 Common Stock 320,000 $2.95 Direct F3
holding MEIP Stock Option (Right to Buy) 130,000 05 Jul 2022 Common Stock 130,000 $1.21 Direct F4
holding MEIP Stock Option (Right to Buy) 25,000 05 Jul 2022 Common Stock 25,000 $1.38 Direct F4
holding MEIP Stock Option (Right to Buy) 65,000 05 Jul 2022 Common Stock 65,000 $2.88 Direct F4
holding MEIP Stock Option (Right to Buy) 130,000 05 Jul 2022 Common Stock 130,000 $4.28 Direct F5
holding MEIP Stock Option (Right to Buy) 150,000 05 Jul 2022 Common Stock 150,000 $2.52 Direct F6
holding MEIP Stock Option (Right to Buy) 150,000 05 Jul 2022 Common Stock 150,000 $3.49 Direct F7
holding MEIP Stock Option (Right to Buy) 75,000 05 Jul 2022 Common Stock 75,000 $3.55 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on July 5, 2022, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
F2 One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
F3 One-quarter of such options vested on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
F4 All options are currently exercisable.
F5 One-quarter of such options vested on July 12, 2019, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
F6 One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
F7 One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
F8 One-quarter of such options vested on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022.